The enzyme enoyl-ACP reductase (FabI)
is the limiting step of the
membrane’s fatty acid biosynthesis in bacteria and a druggable
target for novel antibacterial agents. The FabI active form is a homotetramer,
which displays the highest affinity to inhibitors. Herein, molecular
dynamics studies were carried out using the structure of FabI in complex
with known inhibitors to investigate their effects on tetramerization.
Our results suggest that multimerization is essential for the integrity
of the catalytic site and that inhibitor binding enables the multimerization
by stabilizing the substrate binding loop (SBL, L:195-200) coupled
with changes in the H4/5 (QR interface). We also observed that AFN-1252
(naphtpyridinone derivative) promotes unique conformational changes
affecting monomer–monomer interfaces. These changes are induced
by AFN-1252 interaction with key residues in the binding sites (Ala95,
Tyr146, and Tyr156). In addition, the analysis of water trajectories
indicated that AFN-1252 complexes allow more water molecules to enter
the binding site than triclosan and MUT056399 complexes. FabI–AFN-1252
simulations show accumulation of water molecules near the Tyr146/147
pocket, which can become a hotspot to the design of novel FabI inhibitors.